Triana L.
- Country
- Belgium
- Department
- Gastroenterology
Research Overview
- A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tulisokibart in Participants with Moderately to Severely Active Ulcerative Colitis
- Long-Term Efficacy and Safety Evaluation of Mirikizumab in Patients with Moderately to Severely Active Ulcerative Colitis: A Phase 3, Multicenter, Open-Label Extension Study
- Evaluation of Therapeutic Escalation with Infliximab in Postoperative Recurrence of Crohn's Disease: A Randomized Controlled Trial
Data & Insights
Has run more than one trial at 183 of 316 partner sites.
Specializations
Inflammatory Bowel Disease Management
This investigator specializes in treating inflammatory bowel diseases, with particular emphasis on both Crohn's disease and ulcerative colitis. Their research encompasses innovative therapeutic approaches for patients with moderate to severe disease activity.
- Advanced Biological Therapies
- Post-operative Disease Management
- Treatment Target Optimization
Novel Therapeutic Investigations
The investigator focuses on evaluating emerging treatments including mirikizumab and obefazimod for inflammatory bowel conditions. Their work includes assessment of both induction and maintenance therapy approaches.
- Long-term Treatment Efficacy
- Combination Therapy Strategies
- Therapeutic Drug Monitoring
Clinical Symptom Management
Expertise extends to managing specific disease manifestations, particularly bowel urgency in ulcerative colitis and endoscopic recurrence in Crohn's disease. The investigator studies targeted therapeutic approaches for symptomatic improvement.
- Endoscopic Improvement Assessment
- Symptomatic Remission Strategies
- Disease Activity Monitoring
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.